Kyobo Life Insurance's headquarters in Seoul South Korea’s Supreme Court on Wednesday upheld the ruling that would allow the Affinity Equity Partners-led consortium, including Singapore’s GIC, to make a long-delayed exit from Kyobo Life Insurance Co. at more than 1.5 times their investment of 1.2 trillion won ($930 million).
Ending a five-year legal dispute between Kyobo and the investors, the highest court in South Korea cleared three accountants at Deloitte Anjin and two employees of Affinity Equity Partners of charges that they had unfairly inflated the value of unlisted Kyobo to help the group's divestment for hefty gains.
The verdict will likely pave the way for the Affinity-led investors, which includes Baring Private Equity and IMM Private Equity, to finally exit from Kyobo after more than a decade.
Kyobo Life Insurance Chairman Shin Chang-jae PUT OPTION
Back in 2012, the Affinity-led consortium acquired a combined 24% stake in Kyobo for 1.2 trillion won from then Daewoo International Co., currently POSCO International Corp.
The stock purchase came with a put option, which allowed them to sell Kyobo shares back to Kyobo, including its Chairman Shin Chang-jae, if the insurer failed to go public by September 2015.
As its IPO has dragged on, the Affinity-led group in late 2018 decided to exercise the option, calling on Kyobo Life's top shareholder and Chairman Shin to buy back their shares at 410,000 won apiece. That is 1.65 times higher than their purchase price of 245,000 won.
LEGAL DISPUTE
The Kyobo chairman rejected the put option request and argued that the valuation was based on a falsified financial report in return for alleged bribes paid by the investor consortium.
We use cookies to provide the best user experience. By continuing to browse this website, you will be considered to accept cookies. Please review our Privacy Policy to learn our cookie policy.